IN8bio (INAB) EBITDA (2020 - 2026)
IN8bio (INAB) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM IN8bio (INAB) EBITDA is -$18M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
IN8bio (INAB) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -31.97% |
| 3 Years TTM | -15.24% |
| 5 Years TTM | +14.54% |
| All Time TTM | +14.54% |
Annual EBITDA change of IN8bio (INAB)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$4.84M | -73.75% |
| 2025 | -$18M | -37.41% |
| 2024 | -$29M | +1.45% |
| 2023 | -$29M | +2.36% |
| 2022 | -$28M | +94.85% |
| 2021 | -$15M | +71.90% |
| 2020 | -$8.47M | N/A |
Comparison IN8bio (INAB) five years EBITDA CAGR with competitors
IN8bio (INAB) five years EBITDA CAGR is 14.56%.